Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Triple-negative Breast Cancer
Interventions: DRUG: brostallicin|DRUG: cisplatin
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)